Acute Kidney Injury Induces Remote Cardiac Damage and Dysfunction Through the Galectin-3 Pathway

[1]  A. Go,et al.  Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[2]  N. Houstis,et al.  Cardiac macrophages promote diastolic dysfunction , 2018, The Journal of experimental medicine.

[3]  Kathleen F. Kerr,et al.  Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac Surgery. , 2017, Journal of the American Society of Nephrology : JASN.

[4]  C. Mueller,et al.  Origin of Cardiac Troponin T Elevations in Chronic Kidney Disease. , 2017, Circulation.

[5]  F. Tavora,et al.  Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy. , 2017, The American journal of pathology.

[6]  D. Hering,et al.  R1 autonomic nervous system in acute kidney injury , 2017, Clinical and experimental pharmacology & physiology.

[7]  Rajit K. Basu,et al.  Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults , 2017, The New England journal of medicine.

[8]  A. Levin,et al.  Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[10]  J. Kellum,et al.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. , 2016, JAMA.

[11]  M. Emdin,et al.  Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice , 2016, Hypertension.

[12]  A. Mebazaa,et al.  Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study , 2015, BMC Anesthesiology.

[13]  F. Zannad,et al.  Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension , 2015, Hypertension.

[14]  M. Nangaku,et al.  Regulation of Mitochondrial Dynamics by Dynamin-Related Protein-1 in Acute Cardiorenal Syndrome. , 2015, Journal of the American Society of Nephrology : JASN.

[15]  Y. Eishi,et al.  Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury , 2014, Intensive Care Medicine Experimental.

[16]  H. Sørensen,et al.  Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: a population-based cohort study , 2014, Critical Care.

[17]  S. Bagshaw,et al.  Neutrophil Gelatinase-Associated Lipocalin: Ready for Routine Clinical Use? An International Perspective , 2014, Blood Purification.

[18]  D. Hsu,et al.  Galectin-3 regulates the innate immune response of human monocytes. , 2013, The Journal of infectious diseases.

[19]  Z. Dong,et al.  Mouse model of ischemic acute kidney injury: technical notes and tricks. , 2012, American journal of physiology. Renal physiology.

[20]  C. Delcayre,et al.  Aldosterone Inhibits Antifibrotic Factors in Mouse Hypertensive Heart , 2012, Hypertension.

[21]  Yap Sc,et al.  Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. , 2012 .

[22]  H. T. Lee,et al.  Acute Kidney Injury and Extrarenal Organ Dysfunction: New Concepts and Experimental Evidence , 2012, Anesthesiology.

[23]  A. MacKinnon,et al.  Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3 , 2012, Transplantation.

[24]  P. Ponikowski,et al.  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[25]  D. J. Veldhuisen,et al.  Galectin‐3: a novel mediator of heart failure development and progression , 2009, European journal of heart failure.

[26]  Peter C Austin,et al.  Some Methods of Propensity‐Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations , 2009, Biometrical journal. Biometrische Zeitschrift.

[27]  N. Câmara,et al.  A Role for galectin‐3 in renal tissue damage triggered by ischemia and reperfusion injury , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[28]  L. Burrell,et al.  Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin‐converting enzyme 2 expression , 2008, Experimental physiology.

[29]  J. Iredale,et al.  Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. , 2008, The American journal of pathology.

[30]  Yuan Zhang,et al.  Macrophage Infiltration and Cellular Proliferation in the Non-Ischemic Kidney and Heart following Prolonged Unilateral Renal Ischemia , 2007, Nephron Physiology.

[31]  Y. Pinto,et al.  Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? , 2006, Journal of the American College of Cardiology.

[32]  C. Price,et al.  B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  D. Basile,et al.  Enhanced skeletal muscle arteriolar reactivity to ANG II after recovery from ischemic acute renal failure. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[34]  E. Shapiro,et al.  Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit , 2005 .

[35]  Yigal M. Pinto,et al.  Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction , 2004, Circulation.

[36]  K. Kelly.  Distant effects of experimental renal ischemia/reperfusion injury. , 2003, Journal of the American Society of Nephrology : JASN.

[37]  L. Yu,et al.  This information is current as Macrophages Chemoattractant for Monocytes and Human Galectin-3 Is a Novel , 2000 .

[38]  C. Colnot,et al.  Embryonic implantation in galectin 1/galectin 3 double mutant mice , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[39]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[40]  F. Zannad,et al.  The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. , 2015, JACC. Heart failure.

[41]  J. Joles,et al.  Cardiorenal syndrome—current understanding and future perspectives , 2014, Nature Reviews Nephrology.